Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial
2003 · Arthritis & Rheumatism · 1,751 citations
https://doi.org/10.1002/art.10697